Most Popular

Top 3 Defensive Stocks You'll Regret Missing In October

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared …

Read more

MAPS Investors Have Opportunity to Lead WM Technology, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Oct. 31, 2024 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against WM Technology, Inc. (“WM Technology” or the “Company”) MAPS. Class Period: May 25, 2021 – …

Read more

1 Cathie Wood Stock to Buy Right This Instant That Has 36% Upside, According to Wall Street

Cathie Wood might be best known for her bullish stands on Tesla or Palantir, but recently the outspoken investor has been quietly building a position in up-and-coming fintech player SoFi Technologies (NASDAQ: SOFI). Right now, SoFi is Wood’s fourth-largest position across her portfolio of exchange-traded …

Read more

Apple (AAPL) Q4 2024 Earnings Call Transcript

Image source: The Motley Fool. Apple (NASDAQ: AAPL)Q4 2024 Earnings CallOct 31, 2024, 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Suhasini Chandramouli — Director, Investor Relations Good afternoon, and welcome to the Apple Q4 fiscal year 2024earnings conference call …

Read more

Can META's Solid Q3 Earnings Beat & AI Focus Push the Stock Higher?

Meta Platforms META reported third-quarter 2024 earnings of $6.03 per share, beating the Zacks Consensus Estimate by 16.18%. The figure surged 37.4% year over year. META’s earnings beat the Zacks Consensus Estimate in all the trailing four quarters, the average surprise being 11.34%. Find the …

Read more

Notable Two Hundred Day Moving Average Cross – IOVA

In trading on Thursday, shares of Iovance Biotherapeutics Inc (Symbol: IOVA) crossed below their 200 day moving average of $10.62, changing hands as low as $10.45 per share. Iovance Biotherapeutics Inc shares are currently trading off about 5.1% on the day. The chart below shows …

Read more

Apple Earnings: Tech Rally Under Threat as Investors Assess AI, iPhone 16 Demand

Anticipation for Apple’s results grows amid recent Big Tech earnings volatility. Investors closely watch iPhone demand and the impact of Apple Intelligence on sales. Ambitious forecasts could sidestep any earnings disappointment, but the stock looks overvalued. Looking for actionable trade ideas to navigate the current …

Read more

Best Growth Stocks to Buy for October 31st

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, October 31: BRF S.A. BRFS: This meat processing company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.3% over the …

Read more

Top 3 Consumer Stocks That May Rocket Higher In Q4

The most oversold stocks in the consumer discretionary sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared …

Read more

Metagenomi, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Metagenomi, Inc.

Upcoming Lead Plaintiff Deadline is November 25, 2024 NEW YORK, Oct. 30, 2024 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein“) announces that a federal securities class action lawsuit has been filed in the United States District Court for the Northern District …

Read more